Michelle Robertson
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Michelle Robertson
Michelle Robertson is recorded as CFO at Editas Medicine, Inc. (EDIT). The proxy statement of Editas Medicine, Inc. reports total compensation of $1,577,496 for Michelle Robertson in fiscal 2023, including a base salary of $303,464. Disclosed compensation is on record for 3 fiscal years. Michelle Robertson has spoken on 12 earnings calls across 1 company, most recently for Editas Medicine, Inc. on May 5, 2023.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Editas Medicine, Inc.
Other people whose current roles at this company are on record from its filings.
- Gilmore O'Neill, M.B., M.M.Sc. CEO, Board Member
- James C. Mullen CEO
- Katrine S. Bosley CEO
- Jessica Hopfield Chairman
- Amy Parison CFO
- Andrew A. F. Hack CFO
- Eric Ek CFO
- Erick J. Lucera CFO
- Vic Myer CTO
- Bernadette Connaughton Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Editas Medicine, Inc. (EDIT) | Former Executive Vice President and Chief Financial Officer | $303,464 | $1,577,496 |
| 2022 | Editas Medicine, Inc. (EDIT) | Former Executive Vice President and Chief Financial Officer | $450,915 | $3,422,086 |
| 2021 | Editas Medicine, Inc. (EDIT) | Former Executive Vice President and Chief Financial Officer | $415,754 | $2,247,017 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.